Kim S - Search Results

1

Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma.

Choi S, Kim HR, Sung CO, Kim J, Kim S, Ahn SM, Choi CM, Chun SM, Choi EK, Kim SW, Kim YH, Lee JY, Song JS, Kim D, Haq F, Lee SY, Lee JE, Jung WR, Jang HY, Yang E, Lee C, Yu E, Kong G, Baek D, Jang SJ. Choi S, et al. Among authors: kim yh, kim sw, kim d, kim s, kim hr, kim j. Clin Cancer Res. 2015 Jun 1;21(11):2613-23. doi: 10.1158/1078-0432.CCR-14-0519. Epub 2014 Oct 7. Clin Cancer Res. 2015. PMID: 25294902

2

Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC).

Lee SW, Choi EK, Chung WK, Shin KH, Ahn SD, Kim JH, Kim SW, Suh C, Lee JS, Kim WS, Kim DS, Kim DK, Park SI, Sohn KH. Lee SW, et al. Lung Cancer. 2002 Jul;37(1):65-71. doi: 10.1016/s0169-5002(02)00026-0. Lung Cancer. 2002. PMID: 12057869 Clinical Trial.

3

Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.

Lee SW, Choi EK, Lee JS, Lee SD, Suh C, Kim SW, Kim WS, Ahn SD, Yi BY, Kim JH, Noh YJ, Kim SS, Koh Y, Kim DS, Kim WD. Lee SW, et al. Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):996-1004. doi: 10.1016/s0360-3016(03)00127-5. Int J Radiat Oncol Biol Phys. 2003. PMID: 12829135 Clinical Trial.

4

Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.

Kim YS, Yoon SM, Choi EK, Yi BY, Kim JH, Ahn SD, Lee SW, Shin SS, Lee JS, Suh C, Kim SW, Kim DS, Kim WS, Park HJ, Park CI. Kim YS, et al. Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):76-81. doi: 10.1016/j.ijrobp.2004.09.038. Int J Radiat Oncol Biol Phys. 2005. PMID: 15850905 Clinical Trial.

5

A phase I and pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer.

Lee DH, Kim SW, Bae KS, Hong JS, Suh C, Kang YK, Lee JS. Lee DH, et al. Clin Cancer Res. 2007 Oct 15;13(20):6182-6. doi: 10.1158/1078-0432.CCR-07-0534. Clin Cancer Res. 2007. PMID: 17947485 Clinical Trial.

6

Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer?

Ahn MJ, Park BB, Ahn JS, Kim SW, Kim HT, Lee JS, Kang JH, Cho JY, Song HS, Park SH, Sohn CH, Shin SW, Choi JH, Ki CS, Park CK, Holmes AJ, Jänne PA, Park K. Ahn MJ, et al. Clin Cancer Res. 2008 Jun 15;14(12):3860-6. doi: 10.1158/1078-0432.CCR-07-4608. Clin Cancer Res. 2008. PMID: 18559606 Clinical Trial.

7

[18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung.

Sohn HJ, Yang YJ, Ryu JS, Oh SJ, Im KC, Moon DH, Lee DH, Suh C, Lee JS, Kim SW. Sohn HJ, et al. Clin Cancer Res. 2008 Nov 15;14(22):7423-9. doi: 10.1158/1078-0432.CCR-08-0312. Clin Cancer Res. 2008. PMID: 19010859

8

Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy.

Lee DH, Park K, Kim JH, Lee JS, Shin SW, Kang JH, Ahn MJ, Ahn JS, Suh C, Kim SW. Lee DH, et al. Clin Cancer Res. 2010 Feb 15;16(4):1307-14. doi: 10.1158/1078-0432.CCR-09-1903. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145166 Clinical Trial.

9

Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients.

Lee DH, Choi CM, Kim SW, Suh C, Lee JS. Lee DH, et al. Med Oncol. 2012 Jun;29(2):640-3. doi: 10.1007/s12032-011-9944-6. Epub 2011 Apr 16. Med Oncol. 2012. PMID: 21499804 Clinical Trial.

10

FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy.

Yoon DH, Baek S, Choi CM, Lee DH, Suh C, Ryu JS, Moon DH, Lee JS, Kim SW. Yoon DH, et al. Among authors: kim sw. Clin Cancer Res. 2011 Aug 1;17(15):5093-100. doi: 10.1158/1078-0432.CCR-10-2791. Epub 2011 Jun 14. Clin Cancer Res. 2011. PMID: 21673067 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124,417 results

Search Page

Filters